Safe Biologics

JULY 13, 2023

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). REGISTER HERE.

Drug Pricing 100

Drug Pricing Biosimilars 100

Safe Biologics

JULY 13, 2023

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). REGISTER HERE.

Drug Pricing 100

Drug Pricing Biosimilars 100

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

Biosimilars 130

Biosimilars Drug Pricing Compounding Drug Development 130

The Pharmacist

JANUARY 15, 2024

Pharmacies offering the new Hypertension Case-Finding Service need to focus on converting more patients to ambulatory blood pressure monitoring (ABPM), according to a recent webinar by Community Pharmacy England (CPE).

Community Pharmacies 99

Community Pharmacies 99

Putting Patients First Blog

SEPTEMBER 22, 2023

NHC Weight Management and Health Webinar Event Time: 1:00 - 2:00 p.m. ET Event Location: Virtual The National Health Council invites you to join us for a webinar on weight management and health on Thursday, October 19 from 1-2 p.m. This webinar is open to all NHC members and the public.

98

98

Safe Biologics

MAY 5, 2023

On April 30th, the Generics and Biosimilar Initiative (GaBI) published a meeting report on a 2-hour webinar entitled “Non-Medical Switching of Biologicals and Biosimilars: Canada, Europe, and the US”, hosted July 20th, 2022 by ASBM and GaBI. Watch video of the webinar here.

Biosimilars 100

Biosimilars 100

Safe Biologics

MAY 5, 2023

On April 30th, the Generics and Biosimilar Initiative (GaBI) published a meeting report on a 2-hour webinar entitled “Non-Medical Switching of Biologicals and Biosimilars: Canada, Europe, and the US”, hosted July 20th, 2022 by ASBM and GaBI. Watch video of the webinar here.

Biosimilars 100

Biosimilars 100

Safe Biologics

JULY 20, 2023

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). REGISTER HERE.

Biosimilars 130

Biosimilars Drug Pricing Drug Development 130

Safe Biologics

JULY 20, 2023

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). REGISTER HERE.

Biosimilars 130

Biosimilars Drug Pricing Drug Development 130

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

Biosimilars 100

Biosimilars Drug Pricing Compounding Drug Development 100

Drug Channels

JANUARY 16, 2024

My recent Drug Channels Outlook 2024 webinar covered 12 key trends that will shape the commercial environment this year. As I explain, this growth will challenge payer and channel economics, while boosting profits for patient reimbursement hub businesses and pharmacy benefit managers (PBMs). My first webinar will be on April 5, 2024.

81

81

Drug Channels

MARCH 5, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. This event is part of The Drug Channels 2024 Video Webinar Series.

Drug Pricing 85

Drug Pricing Biosimilars 85

Outsourcing Pharma

JULY 1, 2021

On July 7, a group of seasoned industry leaders will offer insights at Rare/orphan diseases, special patient population, a focused, free online event.

59

59

The Pharmacist

JANUARY 16, 2024

For the first time, placements must provide trainees with experience in both a dispensing and a patient facing setting, with access to a designated prescribing practitioner. During a recent webinar, […] The post NHSE shares advice for listing training placements on Oriel appeared first on The Pharmacist.

95

95

Drug Channels

AUGUST 1, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. Click here if you can’t see the video below. d/b/a Drug Channels Institute.

78

78

Safe Biologics

DECEMBER 3, 2023

ASBM and GaBI Webinar Examines Policy Challenges to Interchangeable Biosimilars On November 30, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted I nterchangeable Designation for Biosimilars- Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars.

Biosimilars 130

Biosimilars Labelling Drug Pricing Packaging 130

Express Pharma

OCTOBER 18, 2023

In addition, low-cyclics Liveo MG 7-9960 SSA is non-sensitising, non-irritating and non-cytotoxic, making it ideally suited to protect the highly sensitive and fragile skin of populations including children, the elderly, and patients with skin conditions or open wounds.” 13 through 16 in Dusseldorf, Germany.

101

101

Safe Biologics

FEBRUARY 1, 2024

In January, the Generics and Biosimilars Initiative (GaBI) published a whitepaper entitled “ Medicare Drug Price Negotiations: Impact on Healthcare Development and Patient Access to Medicines” The paper’s content is drawn from a webinar on the same topic hosted by ASBM and GaBI on July 26, 2023.

Drug Pricing 100

Drug Pricing Biosimilars 100

Drug Channels

OCTOBER 5, 2023

IMHO, this was a huge win for patients thanks to the HIV + Hepatitis Policy Institute, the Diabetes Patient Advocacy Coalition, and the Diabetes Leadership Council. I then follow the dollar to show how they impact plan, patient, and manufacturer costs when compared with traditional approaches to copay support.

Diabetes 77

Diabetes 77

pharmaphorum

OCTOBER 25, 2022

During the six-week-long trial, patients’ fear of movement had reduced significantly, their quality of life had improved, and perceived impression of change towards better significantly improved. The webinar includes thoughts and experiences from our side, as well as from our customer, Sammeli Liikkanen from Orion Corporation.

98

98

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing. and 12.4.3.

75

75

Outsourcing Pharma

JULY 9, 2021

During the Rare/Orphan Diseases, Special Patient Population webinar, a group of industry experts discussed challenges and opportunities faced in the field.

105

105

Outsourcing Pharma

NOVEMBER 11, 2021

During our November 17 webinar Patient-centric solutions, a group of professionals representing a range of perspectives will share ideas and innovations.

98

98

Drug Channels

JUNE 22, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing.

89

89

Drug Channels

AUGUST 4, 2023

Jonas describes the challenges patients face when accessing specialty therapies and explains how patient abandonment affects manufacturers over time. He argues that an effective telemedicine program can help patients via an end-to-end digital experience. To learn more, register for Phil’s free webinar on August 29th at 2 p.m.

78

78

pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. The webinar will also cover: Building better relationships between pharma/CROs and patient advocates.

Documentation 116

Documentation Pharmaceutical Companies Pharmaceutical Companies Hospitals 116

Putting Patients First Blog

SEPTEMBER 22, 2023

NHC Webinar Briefing on the Pharmacy Sector Event Time: 12:00 - 1:15 p.m. This virtual session is intended to inform and engage patient groups and partners in understanding trends, priorities, challenges, and opportunities facing pharmacists and the pharmacy field at large.

52

52

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Patients get access to market prices that can be lower than their PBM’s contracted rate. Links below.

79

79

Pharmaceutical Technology

MAY 26, 2023

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar.

Immunity 105

Immunity Immunization Vaccines Compounding 105

Drug Channels

DECEMBER 12, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2023. During Friday’s webinar, I’ll be sharing my updated thoughts about the IRA’s impact on manufacturers, Part D plans, and patient behavior. 117-169).

Biosimilars 97

Biosimilars Hospitals 97

Drug Channels

OCTOBER 12, 2023

He explains how pharma brand teams and hub program managers can lessen the impact of accumulators and maximizers on patients’ access and adherence.

82

82

Safe Biologics

NOVEMBER 12, 2023

View the full webinar here or watch individual segments linked below. In the letter, ASBM Executive Director Michael Reilly stresses the importance of this data to physicians: Physicians and patients worldwide value data, including switching studies. Read the full letter here. Comments may be submitted here.

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

pharmaphorum

FEBRUARY 2, 2021

Studies that follow a virtual, decentralised, hybrid or remote model can offer many patient recruitment benefits including improvements in terms of enabling a more diverse patient population to participate. The webinar will also cover: Harnessing the UK’s linked-up data systems. Increasing patient access to clinical trials.

Diabetes 71

Diabetes 71

Drug Channels

JUNE 9, 2022

Edward offers five ways life sciences companies can use technology to transform their patient support services and thus differentiate their products. To learn more, sign up for AssistRx’s free webinar Specialty Pharma’s 2022 Patient Support Trends: Progress Check. Read on for Edward’s insights. d/b/a Drug Channels Institute.

81

81

Drug Channels

APRIL 21, 2022

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBM Industry Update: Trends, Controversies, and Outlook. Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. Click here to see the original post and comments from October 2021.

Hospitals 79

Hospitals 79

Drug Channels

JUNE 24, 2022

Logan describes how some patient affordability vendors capture funds that were intended for patients. To learn more, register for Paysign’s July 13 webinar: Affording Patient Affordability Programs: The Truth About Voucher and Bridge Pricing.

78

78

pharmaphorum

DECEMBER 7, 2022

Patient centricity is a high priority these days for pharma companies, who are discovering the value of letting patients’ needs guide the development of therapies and interventions, not only to the patients but to their own outcomes and bottom lines.

52

52